Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Fuchs

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Neurobiology of Disease|June 22, 2014
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signalingClaudia Fuchs, Stefania Trazzi, Roberta Torricella, et al.
World Journal of Gastrointestinal Surgery|June 20, 2020
Software improvement for evaluation of laryngopharyngeal pH testing (Restech) - a comparison between DataView 3 and 4Dolores Thea Müller, Elena Schulte, Benjamin Babic, et al.
Neuropharmacology|August 31, 2019
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorderClaudia Fuchs, Laura Gennaccaro, Elisa Ren, et al.
International Journal of Molecular Sciences|June 2, 2021
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of <i>CDKL5</i> Deficiency DisorderManuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.
Neural Plasticity|July 7, 2018
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 DisorderClaudia Fuchs, Laura Gennaccaro, Stefania Trazzi, et al.
Frontiers in Cellular Neuroscience|May 23, 2019
Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB AgonistElisa Ren, Vincenzo Roncacé, Stefania Trazzi, et al.
CNS Neuroscience & Therapeutics|August 6, 2022
Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorderClaudia Fuchs, Livia Cosentino, Chiara Urbinati, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Human Molecular Genetics|July 29, 2016
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorderStefania Trazzi, Claudia Fuchs, Rocchina Viggiano, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Neurobiology of Disease|June 22, 2014
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signalingClaudia Fuchs, Stefania Trazzi, Roberta Torricella, et al.
World Journal of Gastrointestinal Surgery|June 20, 2020
Software improvement for evaluation of laryngopharyngeal pH testing (Restech) - a comparison between DataView 3 and 4Dolores Thea Müller, Elena Schulte, Benjamin Babic, et al.
Neuropharmacology|August 31, 2019
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorderClaudia Fuchs, Laura Gennaccaro, Elisa Ren, et al.
International Journal of Molecular Sciences|June 2, 2021
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of <i>CDKL5</i> Deficiency DisorderManuela Loi, Laura Gennaccaro, Claudia Fuchs, et al.
Neural Plasticity|July 7, 2018
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 DisorderClaudia Fuchs, Laura Gennaccaro, Stefania Trazzi, et al.
Frontiers in Cellular Neuroscience|May 23, 2019
Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB AgonistElisa Ren, Vincenzo Roncacé, Stefania Trazzi, et al.
CNS Neuroscience & Therapeutics|August 6, 2022
Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorderClaudia Fuchs, Livia Cosentino, Chiara Urbinati, et al.
Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.
Human Molecular Genetics|July 29, 2016
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorderStefania Trazzi, Claudia Fuchs, Rocchina Viggiano, et al.
Hepatology Communications|January 16, 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytesLaura Valestrand, Kathrine S Nordhus, Thierry Claudel, et al.
Pageof 5